Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002048487 | SCV002300074 | likely benign | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004927797 | SCV005599009 | uncertain significance | not specified | 2024-09-27 | criteria provided, single submitter | clinical testing | The c.10532A>G (p.E3511G) alteration is located in exon 68 (coding exon 68) of the HMCN1 gene. This alteration results from a A to G substitution at nucleotide position 10532, causing the glutamic acid (E) at amino acid position 3511 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003948876 | SCV004759238 | likely benign | HMCN1-related disorder | 2023-04-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |